SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy

SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy

Abstract Background A new strain of human coronavirus (HCoV) spread rapidly around the world. Diabetes and obesity are associated with a worse prognosis in these patients. Congenital Generalized Lipodystrophy (CGL) patients generally have poorly controlled diabetes and require extremely high doses o...

Full description

Bibliographic Details
Main Authors: Mayara Ponte Madeira, Erika Bastos Lima Freire, Virginia Oliveira Fernandes, Grayce Ellen da Cruz Paiva Lima, Ivana da Ponte Melo, Ana Paula Dias Rangel Montenegro, José Ednésio da Cruz Freire, Caroline de Fátima Aquino Moreira-Nunes, Raquel Carvalho Montenegro, Jeová Keny Baima Colares, Renan Magalhães Montenegro Junior, Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO)
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Diabetology & Metabolic Syndrome
Subjects:
SARS-COV-2
COVID-19
Congenital generalized lipodystrophy
Lipodystrophy
Diabetes
Insulin resistance
Online Access:https://doi.org/10.1186/s13098-021-00680-1

Internet

https://doi.org/10.1186/s13098-021-00680-1

Similar Items